For US residents only.

Patient Support

KISQALI

Important Safety Information:


What is the most important information I should know about KISQALI?


KISQALI may cause serious side effects, including:


Heart rhythm problems (QT prolongation). 
KISQALI can cause a heart problem known as QT prolongation. This condition can cause an abnormal heartbeat and may lead to death. Your health care provider should check your heart and do blood tests before and during treatment with KISQALI. Tell your health care provider right away if you have a change in your heartbeat (a fast or irregular heartbeat), or if you feel dizzy or faint.


Liver problems (hepatobiliary toxicity).
KISQALI can cause serious liver problems. Your health care provider should do blood tests to check your liver before and during treatment with KISQALI. Tell your health care provider right away if you get any of the following signs and symptoms of liver problems:

  • yellowing of your skin or the whites of your eyes (jaundice)
  • dark or brown (tea-colored) urine
  • feeling very tired
  • loss of appetite
  • pain on the right side of your stomach area (abdomen)
  • bleeding or bruising more easily than normal

 

Low white blood cell counts (neutropenia). Low white blood cell counts are very common when taking KISQALI and may result in infections that may be severe. Your health care provider should check your white blood cell counts before and during treatment with KISQALI. Tell your health care provider right away if you have signs and symptoms of low white blood cell counts or infections such as fever and chills.


Your health care provider may tell you to decrease your dose, temporarily stop, or completely stop taking KISQALI if you develop certain serious side effects during treatment with KISQALI.


What should I tell my health care provider before taking KISQALI?


Before you take KISQALI, tell your health care provider if you:

  • have any heart problems, including heart failure, irregular heartbeats, and QT prolongation
  • have ever had a heart attack
  • have a slow heartbeat (bradycardia)
  • have problems with the amount of potassium, calcium, phosphorus, or magnesium in your blood
  • have fever, chills, or any other signs or symptoms of infection
  • have liver problems
  • have any other medical conditions
  • are pregnant, or plan to become pregnant. KISQALI can harm your unborn baby
    • If you are able to become pregnant, your health care provider should do a pregnancy test before you start treatment with KISQALI.
    • Females who are able to become pregnant and who take KISQALI should use effective birth control during treatment and for at least 3 weeks after the last dose of KISQALI.
    • Talk to your health care provider about birth control methods that may be right for you during this time.
    • If you become pregnant or think you are pregnant, tell your health care provider right away.
  • are breastfeeding or plan to breastfeed. It is not known if KISQALI passes into your breast milk. Do not breastfeed during treatment with KISQALI and for at least 3 weeks after the last dose of KISQALI


Tell your health care provider about all of the medicines you take,
 including prescription and over-the-counter medicines, vitamins, and herbal supplements. KISQALI and other medicines may affect each other causing side effects. Know the medicines you take. Keep a list of them to show your health care provider or pharmacist when you get a new medicine.


What should I avoid while taking KISQALI?


Avoid eating pomegranate or grapefruit and avoid drinking pomegranate or grapefruit juice during treatment with KISQALI since these may increase the amount of KISQALI in your blood. 


The most common side effects of KISQALI include:

  • nausea
  • tiredness
  • diarrhea
  • hair loss
  • vomiting
  • constipation
  • headache
  • back pain


KISQALI may cause fertility problems if you are male and take KISQALI. This may affect your ability to father a child. Talk to your health care provider if this is a concern for you.


Tell your health care provider if you have any side effect that bothers you or that does not go away.


These are not all of the possible side effects of KISQALI. For more information, ask your health care provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

 

Please see full Prescribing Information including Patient Information.

Approved Use:

KISQALI® (ribociclib) is a prescription medicine used in combination with a certain type of medicine as the first hormonal-based therapy to treat women who have gone through menopause with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has spread to other parts of the body (metastatic).

Important Safety Information:

What is the most important information I should know about KISQALI?

KISQALI may cause serious side effects, including:

Heart rhythm problems (QT prolongation). KISQALI can cause a heart problem kno

... See more
Approved Use:

KISQALI® (ribociclib) is a prescription medicine used in combination with a certain type of medicine as the first hormonal-based therapy to treat women who have gone through menopause with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negati

... See more
KISQALI CARE patient support KISQALI CARE patient support

KISQALI Care Patient Support Program

We understand that starting a new treatment can feel overwhelming, and that you may have a lot of questions. That’s why we created KISQALI Care, a comprehensive patient support program that provides you with a dedicated navigator who can help you get the most out of the available patient support.

Patient Navigator

KISQALI Care Patient Navigator

The KISQALI Care Patient Navigator is available to help you throughout your treatment with KISQALI® (ribociclib). While enrolled in the program, you will receive a series of phone calls from a specially trained navigator to support and guide you through various aspects of starting on KISQALI.

Program features include: 

  • Personal phone calls that fit into your schedule
  • Educational information about your medication 
  • Financial assistance information
  • Support in understanding insurance coverage 
  • Help with identifying/determining pharmacies covered by your plan
  • Assistance with scheduling monitoring tests for eligible patients using our KISQALI Care @ Home Monitoring Program*

*Limitations apply. KISQALI Care @ Home Monitoring is not available to patients with Medicare, Medicaid, or any other federal or state program or residents of Michigan, Minnesota, or Rhode Island. Novartis reserves the right to terminate or modify this program at any time.

This program does not provide medical advice or replace your regular interactions with your health care team.

For more information, call 1-800-282-7630.

KISQALI Free Treatment Program

1 FREE Treatment Cycle of KISQALI and/or FEMARA

Patients are eligible to receive a free 1-treatment cycle supply of KISQALI and/or FEMARA® (letrozole) (including generic letrozole).

Call 1-800-282-7630 or visit www.FreeTreatmentVoucher.com to receive your free treatment voucher. 

This offer is available for patients with a valid prescription for KISQALI and/or FEMARA (including generic letrozole), including for patients who have not been prescribed KISQALI or another Novartis product.

KISQALI 5-Treatment Cycle Access Program

Patients with commercial insurance who are still waiting for their coverage to take effect for KISQALI may be eligible for an additional supply of medication that could continue for up to 5 treatment cycles.*

For more information, talk to your doctor or call 1-800-282-7630 to speak with a KISQALI Care Patient Navigator.

*Limitations apply. Eligible patients must have commercial insurance, a completed Service Request Form, and be experiencing a delay in obtaining coverage for KISQALI. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, Tricare, or any other federal or state program. No purchase necessary. Participation is not a guarantee of insurance coverage. Once coverage is approved, patients will no longer be eligible. Novartis Pharmaceuticals Corporation reserves the right to rescind, revoke, or amend this Program without notice.

Universal Co-Pay Offer

KISQALI and/or FEMARA $0 Co-Pay

You may be eligible for immediate co-pay savings on your next KISQALI and/or FEMARA (including generic letrozole) prescriptions:

  • Commercially insured patients pay $0 per month
  • Novartis will pay the remaining co-pay, up to $15,000 per calendar year, per product*
  • This offer is available for patients with a valid prescription for KISQALI and/or FEMARA (including generic letrozole), including for patients who have not been prescribed KISQALI or another Novartis product

*Limitations apply. Patient must have commercial insurance. Offer is not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice. For full terms and conditions, visit www.CoPay.NovartisOncology.com or call 1-877-577-7756.

See if you're eligible:

KISQALI and FEMARA Co-Pay OfferKISQALI Co-Pay Offer

Government-Insured Patients

If you are covered by Medicaid, Medicare Part D, or a government insurance plan, your KISQALI Care Patient Navigator can help you understand your drug coverage and provide information about resources that may be able to provide financial assistance.

For information, call 1-800-282-7630.

KISQALI Care is brought to you by Novartis Patient Assistance Now Oncology.Novartis Patient Assistance Now Oncology

INDICATION

KISQALI® (ribociclib) is a prescription medicine used in combination with a certain type of medicine as the first hormonal-based therapy to treat women who have gone through menopause with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has spread to other parts of the body (metastatic).

It is not known if KISQALI is safe and effective in children.

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about KISQALI?

KISQALI may cause serious side effects, including:

Heart rhythm problems (QT prolongation). KISQALI can cause a heart problem known as QT prolongation. This condition can cause an abnormal heartbeat and may lead to death. Your health care provider should check your heart and do blood tests before and during treatment with KISQALI. Tell your health care provider right away if you have a change in your heartbeat (a fast or irregular heartbeat), or if you feel dizzy or faint.

Liver problems (hepatobiliary toxicity). KISQALI can cause serious liver problems. Your health care provider should do blood tests to check your liver before and during treatment with KISQALI. Tell your health care provider right away if you get any of the following signs and symptoms of liver problems:

  • yellowing of your skin or the whites of your eyes (jaundice)
  • dark or brown (tea-colored) urine
  • feeling very tired
  • loss of appetite
  • pain on the right side of your stomach area (abdomen)
  • bleeding or bruising more easily than normal

Low white blood cell counts (neutropenia). Low white blood cell counts are very common when taking KISQALI and may result in infections that may be severe. Your health care provider should check your white blood cell counts before and during treatment with KISQALI. Tell your health care provider right away if you have signs and symptoms of low white blood cell counts or infections such as fever and chills.

Your health care provider may tell you to decrease your dose, temporarily stop, or completely stop taking KISQALI if you develop certain serious side effects during treatment with KISQALI.

What should I tell my health care provider before taking KISQALI?

Before you take KISQALI, tell your health care provider if you:

  • have any heart problems, including heart failure, irregular heartbeats, and QT prolongation
  • have ever had a heart attack
  • have a slow heartbeat (bradycardia)
  • have problems with the amount of potassium, calcium, phosphorus, or magnesium in your blood
  • have fever, chills, or any other signs or symptoms of infection
  • have liver problems
  • have any other medical conditions
  • are pregnant, or plan to become pregnant. KISQALI can harm your unborn baby
    • If you are able to become pregnant, your health care provider should do a pregnancy test before you start treatment with KISQALI.
    • Females who are able to become pregnant and who take KISQALI should use effective birth control during treatment and for at least 3 weeks after the last dose of KISQALI.
    • Talk to your health care provider about birth control methods that may be right for you during this time.
    • If you become pregnant or think you are pregnant, tell your health care provider right away.
  • are breastfeeding or plan to breastfeed. It is not known if KISQALI passes into your breast milk. Do not breastfeed during treatment with KISQALI and for at least 3 weeks after the last dose of KISQALI

Tell your health care provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. KISQALI and other medicines may affect each other causing side effects. Know the medicines you take. Keep a list of them to show your health care provider or pharmacist when you get a new medicine.

What should I avoid while taking KISQALI?

Avoid eating pomegranate or grapefruit and avoid drinking pomegranate or grapefruit juice during treatment with KISQALI since these may increase the amount of KISQALI in your blood.

The most common side effects of KISQALI include:

  • nausea
  • tiredness
  • diarrhea
  • hair loss
  • vomiting
  • constipation
  • headache
  • back pain

KISQALI may cause fertility problems if you are male and take KISQALI. This may affect your ability to father a child. Talk to your health care provider if this is a concern for you.

Tell your health care provider if you have any side effect that bothers you or that does not go away.

These are not all of the possible side effects of KISQALI. For more information, ask your health care provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Please see full Prescribing Information including Patient Information.

 

Click here for full Prescribing Information for Femara.